Go Pro

Medicxi Ventures Management (Jersey) Ltd Top Holdings and 13F Report (2026)

About Medicxi Ventures Management (Jersey) Ltd

Investment Activity

  • Medicxi Ventures Management (Jersey) Ltd has $177.42 million in total holdings as of June 30, 2026.
  • Medicxi Ventures Management (Jersey) Ltd owns shares of 3 different stocks, but just 2 companies or ETFs make up 80% of its holdings.
  • About 455.81% of the portfolio was sold this quarter.
  • This quarter, Medicxi Ventures Management (Jersey) Ltd has purchased 4 new stocks and bought additional shares in 0 stocks.
  • Medicxi Ventures Management (Jersey) Ltd sold shares of 1 stock and completely divested from 1 stock this quarter.

Largest Holdings

Aura Biosciences
$21,583,233

Largest Sales this Quarter

NewAmsterdam Pharma
465,543 shares (about $15.78M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofMedicxi Ventures Management (Jersey) Ltd

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
$80,990,6060.0%7,464,57245.6%Healthcare
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
$74,850,776$15,777,252 â–¼-17.4%2,208,63942.2%Healthcare
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$21,583,2330.0%3,039,89212.2%Healthcare
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
$0$792,936,596 â–¼-100.0%00.0%Healthcare

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data